However, in breast cancer patients, low CRIP1 expression could enhance cell proliferation and invasion by enhancing the mitogen-activated protein kinase phosphorylation and reducing the CDC2 phosphorylation (Ludyga et al., 2013). This evidence concerns the gene WNK2 and breast cancer.